Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Saxagliptin 5mg, Once Daily for 52 Weeks on 24 Hour Urine Albumin Creatinine Rate(ACR) , in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycaemic Control on Metformin or/and Acarbose

NCT02462369 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.

NCT NCT02462369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02462369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Saxagliptin 5mg, Once Daily for 52 Weeks on 24 Hour Urine Albumin Creatinine Rate(ACR) , in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycaemic Control on Metformin or/and Acarbose
Lead sponsor
The Second Hospital of Nanjing Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2015
Completion date
October 31, 2017
Enrollment
88 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

microalbuminuria, microalbuminuria /creatinine ratios acr